Online citations, reference lists, and bibliographies.

Superparamagnetic Iron Oxide Nanoparticles: Diagnostic Magnetic Resonance Imaging And Potential Therapeutic Applications In Neurooncology And Central Nervous System Inflammatory Pathologies, A Review

J. Weinstein, C. Varallyay, E. Dósa, S. Gahramanov, B. Hamilton, W. Rooney, L. Muldoon, E. Neuwelt
Published 2010 · Medicine
Cite This
Download PDF
Analyze on Scholarcy
Share
Superparamagnetic iron oxide nanoparticles have diverse diagnostic and potential therapeutic applications in the central nervous system (CNS). They are useful as magnetic resonance imaging (MRI) contrast agents to evaluate: areas of blood–brain barrier (BBB) dysfunction related to tumors and other neuroinflammatory pathologies, the cerebrovasculature using perfusion-weighted MRI sequences, and in vivo cellular tracking in CNS disease or injury. Novel, targeted, nanoparticle synthesis strategies will allow for a rapidly expanding range of applications in patients with brain tumors, cerebral ischemia or stroke, carotid atherosclerosis, multiple sclerosis, traumatic brain injury, and epilepsy. These strategies may ultimately improve disease detection, therapeutic monitoring, and treatment efficacy especially in the context of antiangiogenic chemotherapy and antiinflammatory medications. The purpose of this review is to outline the current status of superparamagnetic iron oxide nanoparticles in the context of biomedical nanotechnology as they apply to diagnostic MRI and potential therapeutic applications in neurooncology and other CNS inflammatory conditions.
This paper references
10.1002/ijc.22385
Sensitivity of magnetic resonance imaging of dendritic cells for in vivo tracking of cellular cancer vaccines.
Pauline Verdijk (2007)
1H2O relaxation in vivo
PR Ros (1995)
10.1002/jmri.20460
Principles of cerebral perfusion imaging by bolus tracking.
L. Østergaard (2005)
10.1097/01.rli.0000197669.80475.dd
Preclinical Safety and Pharmacokinetic Profile of Ferumoxtran-10, an Ultrasmall Superparamagnetic Iron Oxide Magnetic Resonance Contrast Agent
P. Bourrinet (2006)
10.3171/jns.1979.51.1.0053
Capillary ultrastructure in human metastatic brain tumors.
D. Long (1979)
10.1002/ana.410300411
Quantitative measurements of capillary transport in human brain tumors by computed tomography.
Dennis R. Groothuis (1991)
10.1093/brain/123.6.1174
Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation.
A. Bitsch (2000)
10.1159/000087212
Pharmacokinetic Study of Ferumoxytol: A New Iron Replacement Therapy in Normal Subjects and Hemodialysis Patients
R. Landry (2005)
Iron oxide particle
U Modder (2007)
10.1161/STROKEAHA.107.481788
Iron Oxide Particle-Enhanced MRI Suggests Variability of Brain Inflammation at Early Stages After Ischemic Stroke
A. Saleh (2007)
10.1007/s00330-004-2405-2
Capacity of human monocytes to phagocytose approved iron oxide MR contrast agents in vitro
S. Metz (2004)
10.1002/mrm.1910140210
Measurement of tissue blood flow using intravascular relaxation agents and resonance imaging
John C. Gore (1990)
10.1148/radiology.211.3.r99jn46791
Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging.
E. Knopp (1999)
10.1002/mrm.10541
MRI-based monitoring of inflammation and tissue damage in acute and chronic relapsing EAE.
M. Rausch (2003)
10.1002/glia.10083
Chlorotoxin, a scorpion-derived peptide, specifically binds to gliomas and tumors of neuroectodermal origin.
S. A. Lyons (2002)
10.1093/brain/awh068
Blood-brain barrier permeability and monocyte infiltration in experimental allergic encephalomyelitis: a quantitative MRI study.
S. Floris (2004)
10.1200/JCO.1990.8.7.1277
Response criteria for phase II studies of supratentorial malignant glioma.
D. Macdonald (1990)
10.1111/j.1365-2990.2004.00557.x
Imaging of iron oxide nanoparticles by MR and light microscopy in patients with malignant brain tumours.
E. Neuwelt (2004)
10.1007/s11060-006-9195-0
Intracranial Thermotherapy using Magnetic Nanoparticles Combined with External Beam Radiotherapy: Results of a Feasibility Study on Patients with Glioblastoma Multiforme
K. Maier-Hauff (2006)
10.1097/00006123-200105000-00013
Association of Total Dose Intensity of Chemotherapy in Primary Central Nervous System Lymphoma (Human Non-Acquired Immunodeficiency Syndrome) and Survival
D. Kraemer (2001)
10.1097/00001756-199906230-00014
Mitochondrial DNA deletions in acute brain injury.
Roy P McDonald (1999)
10.1093/brain/awn009
Pluriformity of inflammation in multiple sclerosis shown by ultra-small iron oxide particle enhancement.
Machteld M. Vellinga (2008)
Comparison of two superparamagnetic viral-sized iron oxide particles ferumoxides and ferumoxtran-10 with a gadolinium chelate in imaging intracranial tumors.
P. Várallyay (2002)
10.1038/ki.2008.496
Ultrasmall superparamagnetic iron oxides (USPIOs): a future alternative magnetic resonance (MR) contrast agent for patients at risk for nephrogenic systemic fibrosis (NSF)?
E. Neuwelt (2009)
Differential permeability and quantitative MR imaging of a human lung carcinoma brain xenograft in the nude rat.
Peter A. Barnett (1995)
10.1093/brain/awh191
In vivo MRI of brain inflammation in human ischaemic stroke.
A. Saleh (2004)
10.1038/188808a0
The Central Nervous System
F. Golla (1960)
10.1111/j.1750-3639.2000.tb00247.x
Inflammation and stroke: putative role for cytokines, adhesion molecules and iNOS in brain response to ischemia.
G. D. del Zoppo (2000)
10.1002/jmri.21359
Comparison of lipid-rich necrotic core size in symptomatic and asymptomatic carotid atherosclerotic plaque: Initial results.
Vincent C. Cappendijk (2008)
10.1007/BF03256264
Detecting and Treating Cancer with Nanotechnology
Keith Hartman (2012)
10.1007/s00330-005-2807-9
Double-echo perfusion-weighted MR imaging: basic concepts and application in brain tumors for the assessment of tumor blood volume and vascular permeability
H. Uematsu (2005)
Proliferating resident
RA Kauppinen (2007)
10.2174/1389450053345037
Endogenous and exogenous CNS derived stem/progenitor cell approaches for neurotrauma.
I. Kulbatski (2005)
10.1111/j.1523-1755.2005.00598.x
The safety and efficacy of ferumoxytol therapy in anemic chronic kidney disease patients.
B. Spinowitz (2005)
10.1002/nbm.881
Central nervous system inflammatory response after cerebral infarction as detected by magnetic resonance imaging.
A. Saleh (2004)
Microglial activation
EB Ringelstein (2003)
10.1161/01.STR.0000250048.42916.ad
Imaging Inflammation in Acute Brain Ischemia
S. Jander (2007)
Treatment of iron deficiency anaemia with saccharated iron oxide given by the intravenous route.
Douglas G. Cameron (1951)
10.1161/01.STR.0000254548.30258.f2
Inflammatory Response After Ischemic Stroke: A USPIO-Enhanced MRI Study in Patients
N. Nighoghossian (2007)
10.2214/ajr.171.6.9843274
Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas.
T. Sugahara (1998)
10.1002/mrm.1910060205
Dynamic imaging with lanthanide chelates in normal brain: contrast due to magnetic susceptibility effects.
A. Villringer (1988)
10.1016/S0306-4522(02)00954-5
Migration of enhanced green fluorescent protein expressing bone marrow-derived microglia/macrophage into the mouse brain following permanent focal ischemia
R. Tanaka (2003)
10.1002/mrm.20883
Liposome-enhanced MRI of neointimal lesions in the ApoE-KO mouse.
W. Mulder (2006)
10.1016/S1470-2045(08)70125-6
Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas.
D. Brandsma (2008)
10.1182/blood-2004-02-0655
Efficient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRI.
A. Arbab (2004)
10.1152/AJPCELL.00215.2007
In vivo leukocyte labeling with intravenous ferumoxides/protamine sulfate complex and in vitro characterization for cellular magnetic resonance imaging.
Y. Wu (2007)
Iron oxide particle
U Modder (2007)
10.1097/00004424-199303001-00004
Preclinical safety assessment and pharmacokinetics of gadodiamide injection, a new magnetic resonance imaging contrast agent.
E. Harpur (1993)
10.1097/01.rli.0000184756.66360.d3
Comparison of Magnetic Properties of MRI Contrast Media Solutions at Different Magnetic Field Strengths
M. Rohrer (2005)
Systemic inflammatory response depends on initial stroke severity but is attenuated by successful thrombolysis.
K. Sander (2005)
10.1148/radiology.175.2.2326474
Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging.
R. Weissleder (1990)
10.1148/radiology.196.2.7617864
Hepatic MR imaging with ferumoxides: a multicenter clinical trial of the safety and efficacy in the detection of focal hepatic lesions.
Pablo Riera Ros (1995)
10.1038/jcbfm.2009.48
Feridex Preloading Permits Tracking of CNS-Resident Macrophages after Transient Middle Cerebral Artery Occlusion
Erica C. Henning (2009)
10.1016/j.jns.2007.05.004
Neuronal repair and replacement in spinal cord injury
F. Bareyre (2008)
10.1038/sj.jcbfm.9600495
Proliferating Resident Microglia after Focal Cerebral Ischaemia in Mice
Á. Dénes (2007)
10.1002/mrm.1910170123
Quantitative measurement of tissue perfusion and diffusion in vivo.
T. Chenevert (1991)
Diffusion-weighted MR imaging of acute stroke: correlation with T2-weighted and magnetic susceptibility-enhanced MR imaging in cats.
M. Moseley (1990)
10.1016/S1474-4422(03)00353-3
Iron misregulation in the brain: a primary cause of neurodegenerative disorders
Y. Ke (2003)
Proliferating resident
RA Kauppinen (2007)
10.1002/(SICI)1522-2586(199902)9:2<228::AID-JMRI12>3.0.CO;2-K
Improved delineation of human brain tumors on MR images using a long-circulating, superparamagnetic iron oxide agent.
W. S. Enochs (1999)
10.1002/mrm.1910140211
Perfusion imaging with NMR contrast agents.
B. Rosen (1990)
10.1016/j.neuroimage.2007.06.006
Cellular multiparametric MRI of neural stem cell therapy in a rat glioma model
C. Brekke (2007)
10.1002/ana.410040408
Recurrent seizures induced by cortical iron injection: a model of posttraumatic epilepsy.
L. Willmore (1978)
10.3171/JNS/2008/108/2/0320
In vivo tracking of superparamagnetic iron oxide nanoparticle-labeled mesenchymal stem cell tropism to malignant gliomas using magnetic resonance imaging. Laboratory investigation.
X. Wu (2008)
10.1227/01.NEU.0000255350.71700.37
THE POTENTIAL OF FERUMOXYTOL NANOPARTICLE MAGNETIC RESONANCE IMAGING, PERFUSION, AND ANGIOGRAPHY IN CENTRAL NERVOUS SYSTEM MALIGNANCY: A PILOT STUDY
E. Neuwelt (2007)
10.1148/radiol.2231010594
Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging.
S. Cha (2002)
10.1093/brain/awh389
Is the disruption of the blood-brain barrier a prerequisite for cellular infiltration in autoimmune encephalitis?
Martin Bendszus (2005)
10.1111/j.1528-1167.2008.01615.x
Functionalized magnetonanoparticles for MRI diagnosis and localization in epilepsy.
Massoud Akhtari (2008)
10.1111/j.0013-9580.2004.30303.x
Evaluation with alpha-[11C]methyl-L-tryptophan positron emission tomography for reoperation after failed epilepsy surgery.
C. Juhász (2004)
10.1002/mrm.21783
In vivo "hot spot" MR imaging of neural stem cells using fluorinated nanoparticles.
J. Ruiz-Cabello (2008)
10.1016/S0301-0082(98)00034-3
Inflammation and glial responses in ischemic brain lesions
G. Stoll (1998)
10.1002/1522-2594(200006)43:6<845::AID-MRM10>3.0.CO;2-J
Utility of simultaneously acquired gradient-echo and spin-echo cerebral blood volume and morphology maps in brain tumor patients.
K. Donahue (2000)
10.1002/IJC.23306
Magnetic resonance imaging-based detection of glial brain tumors in mice after antiangiogenic treatment.
A. Claes (2008)
Magnetic field and tissue dependencies of human brain longitudinal 1 H 2 O relaxation in vivo
WD Rooney (2007)
10.1126/science.1090585
Molecular Imaging: Looking at Problems, Seeing Solutions
H. Herschman (2003)
10.1002/mrm.21792
Field strength dependence of R1 and R2* relaxivities of human whole blood to ProHance, Vasovist, and deoxyhemoglobin.
Nicholas P. Blockley (2008)
10.1259/bjr/41321492
New developments in MRI for target volume delineation in radiotherapy.
V. Khoo (2006)
10.1080/02841859709171236
Time-dependency in brain lesion enhancement with gadodiamide injection
Pia Karlsland Åkeson (1997)
10.1007/s10439-005-9002-7
Superparamagnetic Iron Oxide Nanoparticle Probes for Molecular Imaging
D. Thorek (2005)
10.1161/STROKEAHA.107.513358
Quantitative Assessment of Core/Penumbra Mismatch in Acute Stroke: CT and MR Perfusion Imaging Are Strongly Correlated When Sufficient Brain Volume Is Imaged
P. Schaefer (2008)
Cerebral blood volume mapping by MR imaging in the initial evaluation of brain tumors.
S. Kremer (2002)
10.1038/jcbfm.2008.162
Dynamic MRI Using Iron Oxide Nanoparticles to Assess Early Vascular Effects of Antiangiogenic versus Corticosteroid Treatment in a Glioma Model
C G Varallyay (2009)
10.1007/s004010000262
Dynamic changes of magnetic resonance imaging abnormalities in relation to inflammation and glial responses after photothrombotic cerebral infarction in the rat brain
M. Schroeter (2000)
10.1097/01.rli.0000135980.08491.33
Macrophage Imaging in Central Nervous System and in Carotid Atherosclerotic Plaque Using Ultrasmall Superparamagnetic Iron Oxide in Magnetic Resonance Imaging
C. Corot (2004)
An exploratory study of ferumoxtran-10 nanoparticles as a blood-brain barrier imaging agent targeting phagocytic cells in CNS inflammatory lesions.
S. P. Manninger (2005)
10.1002/mrm.20749
Assessment of dynamic susceptibility contrast cerebral blood flow response to amphetamine challenge: a human pharmacological magnetic resonance imaging study at 1.5 and 4 T.
Stephen E. Rose (2006)
10.1097/00006123-199404000-00048
Delivery of virus-sized iron oxide particles to rodent CNS neurons.
E. Neuwelt (1994)
10.1016/j.jmr.2006.05.014
Fast and quiet MRI using a swept radiofrequency.
D. Idiyatullin (2006)
10.1016/J.BIOMATERIALS.2007.08.050
Iron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain tumors.
B. Chertok (2008)
10.1046/j.0305-1846.2003.00512.x
Trafficking of superparamagnetic iron oxide particles (Combidex) from brain to lymph nodes in the rat.
L. Muldoon (2004)
10.1227/01.NEU.0000175731.25414.4c
Imaging, Distribution, and Toxicity of Superparamagnetic Iron Oxide Magnetic Resonance Nanoparticles in the Rat Brain and Intracerebral Tumor
L. Muldoon (2005)
10.1002/mrm.1290
Dynamic patterns of USPIO enhancement can be observed in macrophages after ischemic brain damage.
M. Rausch (2001)
Use of chlorotoxin for targeting of primary brain tumors.
L. Soroceanu (1998)
10.1148/radiology.191.1.8134596
Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings.
Hannu J. Aronen (1994)
10.1161/01.STR.0000236063.47539.99
Assessment of Inflammatory Burden Contralateral to the Symptomatic Carotid Stenosis Using High-Resolution Ultrasmall, Superparamagnetic Iron Oxide–Enhanced MRI
T. Tang (2006)
10.1016/J.IJROBP.2007.06.061
Susceptibility contrast magnetic resonance imaging determination of fractional tumor blood volume: a noninvasive imaging biomarker of response to the vascular disrupting agent ZD6126.
S. Robinson (2007)
Contrast enhancement of brain tumors at different MR field strengths: comparison of 0.5 T and 2.0 T.
Kee-hyun Chang (1994)
10.1016/j.neuroimage.2006.03.028
Early macrophage MRI of inflammatory lesions predicts lesion severity and disease development in relapsing EAE
B. Brochet (2006)
10.1097/01.rmr.0000245464.36148.dc
Contrast-Enhanced Magnetic Resonance Imaging of Central Nervous System Tumors: Agents, Mechanisms, and Applications
M. Essig (2006)
10.1021/cr068445e
Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications.
S. Laurent (2008)
MR imaging of cerebral ischemia: findings in the first 24 hours.
W. Yuh (1991)
10.1002/jmri.21337
Positive contrast MR-lymphography using inversion recovery with ON-resonant water suppression (IRON).
Grigorios Korosoglou (2008)
10.1097/00006123-199805000-00085
Outwitting the Blood-Brain Barrier for Therapeutic Purposes: Osmotic Opening and Other Means
P. Dietrich (1998)
10.1148/radiol.2283020322
Targeting of hematopoietic progenitor cells with MR contrast agents.
H. Daldrup-Link (2003)
10.1161/01.STR.20.10.1407
Stroke--1989. Recommendations on stroke prevention, diagnosis, and therapy. Report of the WHO Task Force on Stroke and other Cerebrovascular Disorders.
Lippincott Williams Wilkins (1989)
10.1038/sj.jcbfm.9600241
Present Status of Magnetic Resonance Imaging and Spectroscopy in Animal Stroke Models
R. Weber (2006)
10.1007/s11060-006-9260-8
Ferumoxtran-10 enhancement in orthotopic xenograft models of human brain tumors: an indirect marker of tumor proliferation?
S. Kremer (2006)
10.1002/mrm.21122
Magnetic field and tissue dependencies of human brain longitudinal 1H2O relaxation in vivo.
W. Rooney (2007)
10.1148/radiol.2432060120
Comparison of SPIO and USPIO for in vitro labeling of human monocytes: MR detection and cell function.
Raoul D Oude Engberink (2007)
10.1148/radiol.2351040094
Cell tagging with clinically approved iron oxides: feasibility and effect of lipofection, particle size, and surface coating on labeling efficiency.
L. Matuszewski (2005)
10.1161/01.STR.28.2.382
Phagocytic response in photochemically induced infarction of rat cerebral cortex. The role of resident microglia.
M. Schroeter (1997)
10.1148/radiology.210.3.r99mr44769
Differences between relapsing-remitting and chronic progressive multiple sclerosis as determined with quantitative MR imaging.
Yukio Miki (1999)
10.1113/JPHYSIOL.2007.139451
Cell tracking using magnetic resonance imaging.
M. Hoehn (2007)
Measurement of tissue blood flow using intravascular relaxation agents and magnetic resonance imaging.
John C. Gore (1990)
Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas [corrected].
M. Lev (2004)
10.1038/sj.neo.7900176
Magnetic labeling of activated microglia in experimental gliomas.
G. Fleige (2001)
10.1002/jmri.20057
Predictability of FTY720 efficacy in experimental autoimmune encephalomyelitis by in vivo macrophage tracking: clinical implications for ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging.
M. Rausch (2004)
10.1016/j.biomaterials.2008.09.044
Post-mortem studies in glioblastoma patients treated with thermotherapy using magnetic nanoparticles.
F van Landeghem (2009)
10.1097/00041327-199906000-00031
Computer-assisted quantitation of enhancing lesions in multiple sclerosis: correlation with clinical classification.
Y. Miki (1997)
10.1016/S0014-4886(03)00082-7
Microglial activation precedes and predominates over macrophage infiltration in transient focal cerebral ischemia: a study in green fluorescent protein transgenic bone marrow chimeric mice
M. Schilling (2003)
10.1002/jmri.20039
Survival analysis in patients with glioblastoma multiforme: predictive value of choline-to-N-acetylaspartate index, apparent diffusion coefficient, and relative cerebral blood volume.
J. Oh (2004)
10.1097/00006123-199805000-00082
Outwitting the blood-brain barrier for therapeutic purposes: osmotic opening and other means.
R. Kroll (1998)
10.1016/S1076-6332(03)80422-1
Ultrasmall superparamagnetic iron oxide-enhanced MR imaging of atherosclerotic plaque in hyperlipidemic rabbits.
S. Ruehm (2002)
10.1016/j.jneuroim.2007.11.008
Visualisation of the kinetics of macrophage infiltration during experimental autoimmune encephalomyelitis by magnetic resonance imaging
Kurt Baeten (2008)
10.1162/15353500200403190
Comparison of Transfection Agents in Forming Complexes with Ferumoxides, Cell Labeling Efficiency, and Cellular Viability
A. Arbab (2004)
10.1038/nm1631
In vivo magnetic resonance imaging of acute brain inflammation using microparticles of iron oxide
M. McAteer (2007)
MR imaging of relapsing
JM Caille (2006)
10.1007/978-3-0348-8297-2
Inflammation and Stroke
Giora Z. Feuerstein (2001)
10.1016/j.addr.2006.09.013
Recent advances in iron oxide nanocrystal technology for medical imaging.
C. Corot (2006)
MR imaging of relapsing multiple sclerosis patients using ultra-small-particle iron oxide and compared with gadolinium.
V. Dousset (2006)
10.3109/13550289909021284
Physiology and pathology of the blood-brain barrier: implications for microbial pathogenesis, drug delivery and neurodegenerative disorders.
W. Banks (1999)
Imaging and nanomedicine for diagnosis and therapy in the central nervous system: report of the eleventh annual Blood-Brain Barrier Disruption Consortium meeting.
L. Muldoon (2006)
10.1016/S0079-6123(06)61026-1
In vivo tracking of stem cells in brain and spinal cord injury.
E. Syková (2007)
10.1162/15353500200505145
Cellular MR Imaging
Michel Modo (2005)
10.1002/MRM.21399
Positive contrast visualization of iron oxide-labeled stem cells using inversion-recovery with ON-resonant water suppression (IRON).
M. Stuber (2007)
10.1016/j.ijrobp.2005.09.001
Clinical investigation survival prediction in high-grade gliomas by MRI perfusion before and during early stage of RT
Yue Cao (2006)
Single-dose contrast agent for intraoperative MR imaging of intrinsic brain tumors by using ferumoxtran-10.
M. Hunt (2005)
kidney disease patients
G Stoll (1998)
Physiology and pathology of the bloodbrain barrier: implications for microbial pathogenesis, drug delivery and neurodegenerative disorders
WA Banks (1999)



This paper is referenced by
Nanoparticle-Coated Poly(3-Hydroxybutyrate) Granules For Biomedical Applications
Diego Julián Castiblanco Rey (2012)
10.1021/am401310s
Transfer of ultrasmall iron oxide nanoparticles from human brain-derived endothelial cells to human glioblastoma cells.
Blanka Halamoda Kenzaoui (2013)
10.1016/J.SOLIDSTATESCIENCES.2014.05.006
Preparation of γ-Fe2O3/SiO2-capsule composites capable of using as drug delivery and magnetic targeting system from hydrophobic iron acetylacetonate and hydrophilic SiO2-capsule
Fengzhu Lv (2014)
10.2147/IJN.S65526
Nanopharmaceuticals (part 2): products in the pipeline
Volkmar Weissig (2015)
10.2174/0929867322666150311151403
Iron Oxide Nanoparticles: An Insight into their Biomedical Applications
Diana Couto (2015)
10.1007/s11064-019-02774-9
Iron Oxide Nanoparticles Affects Behaviour and Monoamine Levels in Mice
Vijayprakash Manickam (2019)
10.1002/APP.48040
Magnetic silk fibroin composite nanofibers for biomedical applications: Fabrication and evaluation of the chemical, thermal, mechanical, and in vitro biological properties
Özge Lalegül-Ülker (2019)
10.1016/j.tox.2010.06.002
Inflammatory responses may be induced by a single intratracheal instillation of iron nanoparticles in mice.
E. Park (2010)
10.1016/bs.apha.2014.06.002
Delivery of chemotherapeutics across the blood-brain barrier: challenges and advances.
Nancy D. Doolittle (2014)
10.1007/s11051-014-2270-0
Controlled oxidation of iron nanoparticles in chemical vapour synthesis
Jarno Ruusunen (2014)
10.1111/jon.12318
USPIO-Enhanced MRI Neuroimaging: A Review.
Maria Gkagkanasiou (2016)
10.4324/9781315153544-30
Porous silicon nanotube arrays
Nguyen T. Le (2017)
10.1007/s10565-012-9236-8
Stress reaction of kidney epithelial cells to inorganic solid-core nanoparticles
Blanka Halamoda Kenzaoui (2012)
Role of RORyt+ innate lymphoid tissue inducer cells within breast cancer microenvironments
Sheeba Irshad Kanth (2014)
10.1161/STROKEAHA.110.607994
MRI Using Ferumoxytol Improves the Visualization of Central Nervous System Vascular Malformations
Edit Dósa (2011)
10.19080/mabb.2017.03.555602
Nanoparticles Using as Efficient Bioavailability in Drug Delivery System-Mini Review
Md. Shahed-Al-Mahmud (2018)
10.1016/j.nano.2016.03.009
Ferumoxytol nanoparticle uptake in brain during acute neuroinflammation is cell-specific.
H L McConnell (2016)
10.1089/TEN.TEB.2016.0437
Superparamagnetic Iron Oxide Nanoparticles in Musculoskeletal Biology
R IyerShama (2016)
10.1016/j.actbio.2013.05.022
Endocytotic uptake of iron oxide nanoparticles by cultured brain microglial cells.
Eva Maria Luther (2013)
Title Commercial nanoparticles for stem cell labeling andtracking
Yaqi Wang (2017)
Mapping the Microscale Origins of MRI Contrast with Subcellular NV Diamond Magnetometry
H. Davis (2016)
10.1002/mrm.26800
Establishing the overlap of IONP quantification with echo and echoless MR relaxation mapping
Hattie L Ring (2018)
10.1002/mrm.22942
14.1 T whole body MRI for detection of mesoangioblast stem cells in a murine model of Duchenne muscular dystrophy.
B. E. Odintsov (2011)
10.2176/nmc.st.2019-0034
Macrophage Imaging of Intracranial Aneurysms
Kampei Shimizu (2019)
10.3389/fbioe.2020.00537
Differently Charged Super-Paramagnetic Iron Oxide Nanoparticles Preferentially Induced M1-Like Phenotype of Macrophages
Wenyue Zhang (2020)
10.1586/14737159.2013.819216
Monocytes and macrophages as nanomedicinal targets for improved diagnosis and treatment of disease
Marnix Lameijer (2013)
10.1148/radiol.11103503
Improved perfusion MR imaging assessment of intracerebral tumor blood volume and antiangiogenic therapy efficacy in a rat model with ferumoxytol.
Seymur Gahramanov (2011)
Molecular Imaging of Atherosclerosis
Molekulare Bildgebung der Atherosklerose (2013)
10.1016/J.CEJ.2013.04.009
Improving the quality of nanoparticle production by using a new biphasic synthesis in a slug flow microreactor
Darius Arndt (2013)
following Brain Trauma Lactate Storm Marks Cerebral Metabolism Metabolism
Garnette R. Sutherland (2014)
10.14405/KJVR.2014.54.4.245
Evaluation of thermally cross-linked superparamagnetic iron oxide nanoparticles for the changes of concentration and toxicity on tissues of Sprague-Dawley rats
Jin Joo Hue (2014)
10.1016/j.jconrel.2015.12.013
Targeting specific cells in the brain with nanomedicines for CNS therapies.
Fan Zhang (2016)
See more
Semantic Scholar Logo Some data provided by SemanticScholar